Chemoinformaics analysis of 6-TRANS-PIPERAMIDE-C-7-1
Molecular Weight | 301.386 | nRot | 6 |
Heavy Atom Molecular Weight | 278.202 | nRig | 17 |
Exact Molecular Weight | 301.168 | nRing | 3 |
Solubility: LogS | -3.936 | nHRing | 2 |
Solubility: LogP | 3.454 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 1 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 23 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 18 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
nHA | 3 | APOL | 48.9022 |
nHD | 0 | BPOL | 29.1238 |
QED | 0.753 |
Synth | 2.179 |
Natural Product Likeliness | 0.147 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.981 |
Pgp-sub | 0.01 |
HIA | 0.002 |
CACO-2 | -4.775 |
MDCK | 0.00003 |
BBB | 0.951 |
PPB | 0.959191 |
VDSS | 0.923 |
FU | 0.0439083 |
CYP1A2-inh | 0.975 |
CYP1A2-sub | 0.442 |
CYP2c19-inh | 0.914 |
CYP2c19-sub | 0.301 |
CYP2c9-inh | 0.62 |
CYP2c9-sub | 0.719 |
CYP2d6-inh | 0.936 |
CYP2d6-sub | 0.879 |
CYP3a4-inh | 0.947 |
CYP3a4-sub | 0.202 |
CL | 13.871 |
T12 | 0.511 |
hERG | 0.326 |
Ames | 0.005 |
ROA | 0.026 |
SkinSen | 0.966 |
Carcinogencity | 0.692 |
EI | 0.104 |
Respiratory | 0.39 |
NR-Aromatase | 0.166 |
Antiviral | Yes |
Prediction | 0.687005 |